1.825EUR+0.83%Mkt Cap: 158.73M EURP/E: —Last update: 2026-05-14
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as …
Industry Peers
Medical Care Facilitiesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.93
P/B1.45
P/S0.59
EV/EBITDA16.90
EV/Revenue1.09
EPS (TTM)-0.05
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-4.69%
FCF Margin-2.75%
Operating CF5.09M EUR
CapEx (TTM)16.92M EUR
Net Debt/EBITDA7.94
Net Debt139.24M EUR
Technical
SMA 501.765 (+3.4%)
SMA 2001.924 (-5.1%)
Beta0.84
S&P 52W Chg24.23%
Avg Vol (30d)77.55K
Avg Vol (10d)9.03K
Technical Indicators
RSI (14)51.2
MACD0.0017
MACD Signal0.0129
MACD Hist.-0.0112
BB Upper2.021 EUR
BB Middle1.859 EUR
BB Lower1.696 EUR
BB Width17.52%
ATR (14)0.0604 EUR
Vol Ratio (20d)0.30x
52W Range
1.56034% of range2.350
52W High2.350 EUR
52W Low1.560 EUR
Profitability
Gross Margin20.36%
EBITDA Margin6.48%
Profit Margin-1.69%
Oper. Margin5.58%
ROE-4.49%
ROA-0.88%
Revenue Growth0.80%
Earnings Growth-85.00%
Balance Sheet
Debt/Equity1.76
Current Ratio0.81
Quick Ratio0.71
Book Value/Sh1.265 EUR
Cash/Share0.3020 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield2.45%
Payout Ratio0.00%
Ex-Div DateJul 22, 2024
Pay DateAug 29, 1991
Ownership
Shares Out.86.74M
Float—
Insiders80.82%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap158.73M EUR
Enterprise Value296.50M EUR
Revenue (TTM)270.92M EUR
Gross Profit56.14M EUR
Net Income (TTM)-4.67M EUR
Revenue/Share3.123 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees3.5K
Last Price1.825 EUR
CountryGR
SectorHealthcare
IndustryMedical Care Facilities
ISIN—